جستجوی استاد راهنمای دانشگاهی

Jennifer L. Herrickمشاهده پروفایل

دانشیار

• Hematopathology
• Hemoglobin disorders
• Red blood cell enzymopathies
• +۶ مورد دیگر

Jennifer L. Herrick, M.D. , is a board-certified hematopathologist at the Mayo Clinic in Rochester, Minnesota. She serves as an Associate Professor of Medicine at the Mayo Clinic School of Medicine within the Department of Laboratory Medicine and Pathology . Her clinical expertise spans neoplastic and non-neoplastic blood disorders, with a focus on molecular genetics and diagnostic innovation. Education: MD (University of Nevada School of Medicine, 2001), BS in Chemistry (University of Colorado, 1995 with distinction). Training: Residency and fellowship at Mayo Clinic and University of Texas Health Science Center at San Antonio. Research Interests: Dr. Herrick specializes in hemoglobin disorders, red blood cell enzymopathies, and membrane disorders, with significant work on methemoglobinemia and hereditary erythrocytosis. Her studies bridge clinical diagnostics with molecular mechanisms, including VEXAS syndrome and PICALM::MLLT10 fusion in acute leukemia. Recent Publications highlight her leadership in hematologic malignancy diagnostics, particularly in Acute Myeloid Leukemia and T-cell ALL , utilizing advanced techniques like mass spectrometry and capillary electrophoresis. Her work also includes bone marrow morphology and hemoglobin variant characterization. Scientific Awards: 2025 DLMP Innovation and Leadership in Education Award (Consultant Faculty) 2006 DLMP Innovation and Leadership in Education Award 2006 Rolf Sjuve Scott Award for Excellence in Training 2004 Resident of the Year and Chief Resident (University of Texas Health Science Center at San Antonio) 2001 Janet M. Glasgow Memorial Achievement Citation 1995 Bachelor of Science with distinction and cum laude (University of Colorado)

Benjamin R. Kippمشاهده پروفایل

استاد

• Molecular Genetics
• Clinical Genetics
• Cancer Diagnostics
• +۳ مورد دیگر

Benjamin R. Kipp, Ph.D. , is a board-certified Molecular Geneticist and academic leader at Mayo Clinic. He holds the Professor rank at Mayo Clinic School of Medicine and serves as Division Chair of Laboratory Genetics and Genomics within the Department of Laboratory Medicine and Pathology. His career spans clinical laboratory leadership, research innovation, and education in molecular diagnostics. Education : Ph.D. in Health Sciences (Trident University, 2007); M.S. in Biology (Minnesota State University, Mankato, 2002); B.S. in Human Biology (Minnesota State University, Mankato, 1997); Certificate in Cytotechnology (Mayo Clinic, 2000); Fellowship in Clinical Molecular Genetics (Mayo Clinic, 2011). Research Focus : Development of molecular genetic assays for cancer diagnosis and treatment Clinical NGS technology for hereditary/somatic diseases Molecular cytology applications in solid tumors Circulating tumor DNA analysis for early cancer detection Scientific Contributions : 2009 Anatomic Pathology Award of Excellence 2006 Geno Saccomanno, MD New Frontiers in Cytopathology Award Co-author on 10+ peer-reviewed studies (2015-2025) covering tumor genomics, NGS implementation, and diagnostic innovation Fellow, American College of Medical Genetics and Genomics (2012-present) Leadership Roles : Chair, Advanced Diagnostic Laboratory Oversight Committee (2018-present) Member, Advanced Diagnostic Laboratory Executive Committee (2018-present) Board Member, United States and Canadian Academy of Pathology (2022-2024)

Kevin J. Wuمشاهده پروفایل

پزشک-پژوهشگر

• Pathology
• Oncology
• Urology
• +۳ مورد دیگر

Kevin J. Wu, M.D., is a pathologist at the Mayo Clinic College of Medicine and Science, Jacksonville, Florida. His work spans oncology , urologic pathology , and molecular mechanisms of cancer . Education : MD, University of Arkansas for Medical Sciences (1994); BA, Psychology, University of Arkansas (1990). Dr. Wu's research focuses on renal cell carcinoma , prostate cancer , and urologic tumors , with an emphasis on biomarker discovery and imaging correlations . His publications highlight collaborations in multidisciplinary cancer research and post-treatment complications . Recent articles explore topics such as pancreatic hemangioblastoma in tuberous sclerosis (2024), radiation therapy outcomes in prostate cancer (2023), and molecular targets in renal cell carcinoma (2013). His work has appeared in journals like Clinical Cancer Research , Urologic Oncology , and Mayo Clinic Proceedings . Scientific Awards : Above and Beyond Mayo Clinic Award (2006); Alpha Omega Alpha Honor Medical Society (since 1994). Dr. Wu is actively involved in Digital Pathology initiatives at Mayo Clinic and has served on committees related to clinical equipment and urologic oncology . His expertise combines anatomic pathology , molecular diagnostics , and translational cancer research .

Eunhee S. Yiمشاهده پروفایل

استاد

• Pulmonary Pathology
• Interstitial Lung Diseases
• Lung Transplant Pathology
• +۴ مورد دیگر

Dr. Eunhee S. Yi is a distinguished Professor in the Department of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. With over three decades of experience in pulmonary pathology, she has established herself as a leading expert in interstitial lung diseases, lung transplant pathology, and lung cancer diagnostics. Her clinical work focuses on anatomic pathology with particular expertise in complex pulmonary cases requiring multidisciplinary approaches. Dr. Yi's educational background includes: MD from Seoul National University College of Medicine (1982) Pre-Medical from Seoul National University College of Medicine (1978) MS in Pathology from Seoul National University College of Medicine (1985) PhD coursework in Pathology from Seoul National University College of Medicine (1986) Residency in Anatomic Pathology at Seoul National University Hospital (1986) Residency in Anatomic Pathology at Washington Hospital Center (1990) Residency in Clinical Pathology at University of California, Irvine (1992) Dr. Yi's research focuses on pulmonary pathology with particular expertise in interstitial lung diseases, lung transplant pathology, and lung cancer diagnostics. Her work bridges clinical pathology with translational research, developing novel diagnostic approaches for complex pulmonary conditions. She has made significant contributions to understanding IgG4-related lung disease, pulmonary Langerhans cell histiocytosis, and the pathological features of various interstitial lung diseases. Her research often involves multidisciplinary collaborations with pulmonologists, radiologists, and thoracic surgeons to improve diagnostic accuracy and patient outcomes. Analysis of Dr. Yi's recent publications (2023-2025) reveals a strong focus on translational pathology with emphasis on direct patient-pathologist interactions, advanced diagnostic techniques including immunohistochemistry and genetic testing, and refinement of disease classification systems. Her work demonstrates a consistent trajectory toward integrating traditional pathology with modern molecular diagnostics and artificial intelligence to enhance precision medicine in pulmonary diseases. Dr. Yi has received several prestigious awards recognizing her contributions to pathology education and clinical practice: 2006 Teaching Award for Anatomic Pathology Faculty, University of California 2003 Pathology residents' teaching award for Anatomic Pathology Faculty 1989 Pathology residents' presentation award, Washington Society of Pathologists Throughout her career, Dr. Yi has been actively involved in professional societies including the United States and Canadian Academy of Pathology, American Society for Investigative Pathology, American Thoracic Society, and North American Society of Head and Neck Pathology. She has served on numerous committees including the Nominating Committee of the Pulmonary Pathology Society, Graduate Medical Education Committee at University of California, San Diego, and various quality assurance and research committees. Her mentorship has helped shape the careers of many pathology residents and fellows specializing in pulmonary pathology.

Pingchuan Zhangمشاهده پروفایل

پژوهشگر ارشد

• Renal Pathology
• Nephrology
• Immunofluorescence
• +۷ مورد دیگر

Pingchuan Zhang, M.D., Ph.D., is a faculty member at the Mayo Clinic College of Medicine in the Department of Laboratory Medicine and Pathology . He is based in Rochester, Minnesota, and specializes in Renal Pathology and Cardiovascular Surgery . His work spans Kidney Transplantation , Glomerulonephritis , and Tissue Engineering for cardiac repair. Education: Ph.D. in Surgery, Peking Union Medical College (2006) Masters in Surgery, Sun Yat-sen University (2003) MD, Peking University Medical School (1997) Dr. Zhang's research focuses on Renal Immunopathology (e.g., IgG4-related nephritis, monoclonal immunoglobulin deposits), Diagnostic Accuracy in kidney biopsies (mass spectrometry vs. immunofluorescence), and Cardiovascular Regeneration using biopolymers and progenitor cells. His publications highlight collaborations with leading institutions like Mayo Clinic and University of Ottawa. Article trends show emphasis on Renal Allograft Monitoring , Autoimmune Kidney Diseases , and Advanced Diagnostic Protocols . Key subfields include Transplant Prognostication , Mass Spectrometry Applications , and Cardiac Biomaterials . Scientific Awards: 2nd place podium presentation, Texas Society of Pathologists Annual Meeting (2013) Lawrence Soloway Research Fellowship (University of Ottawa, 2009) Honorable Mention in Basic Science Research (University of Ottawa, 2008) Dr. Zhang maintains active memberships in the American Society of Nephrology , Renal Pathology Society , and United States and Canadian Academy of Pathology . His clinical work includes Kidney Biopsy Analysis and Heart Valve Surgery retrospective studies. Labs and teams: Collaborated with Mayo Clinic's Renal Transplantation Group , University of Ottawa's Cardiovascular Regeneration Lab , and SUN Yat-Sen University's Cardiac Surgery Department .

• Otorhinolaryngology
• Neurobiology
• Hearing Loss
• +۶ مورد دیگر

Luis Angel Vallejo Valdezate is a Professor at the University of Valladolid, affiliated with the Department of Surgery, Ophthalmology, Otorhinolaryngology and Physiotherapy. He is associated with the Castile and Leon Institute of Neuroscience and has contributed extensively to research in Otorhinolaryngology, Hearing Loss, and Neurobiology. Education: PhD (1996) from the University of Valladolid Primary Affiliation: Castile and Leon Institute of Neuroscience (1FA Center) His research focuses on auditory physiology, surgical techniques in otology, and anatomical variations affecting endocrine and ear surgeries. He has pioneered innovations in middle ear prosthetics and nasal obstruction diagnostics. Recent publications highlight advancements in vestibular schwannoma management, thyroid surgery, and mecanoacoustic modeling. His work bridges clinical practice with computational analysis, emphasizing therapeutic success metrics and anatomical precision. He has supervised PhD research, including studies on olfactory bulb modifications following early sensory deprivation, though specific student names are not listed in the provided text.

• Trauma Rehabilitation
• Musculoskeletal Injury Management
• Complex Interventions Development
• +۳ مورد دیگر

David Keene serves as the Kadoorie Professor of Trauma Rehabilitation at the University of Oxford and holds a Senior Research Fellowship at Lincoln College. He is also a Clinical Specialist Physiotherapist at the Royal United Hospitals Bath NHS Foundation Trust, bridging academic research with clinical practice. His work focuses on developing and evaluating complex interventions for musculoskeletal injuries, particularly in trauma rehabilitation. Professor Keene specializes in trauma rehabilitation with particular expertise in musculoskeletal injury management, clinical trial design, and complex intervention development. His research spans orthopaedic rehabilitation across diverse populations including geriatric patients, children with cerebral palsy, and athletes with sports injuries. He has developed numerous rehabilitation protocols for conditions including ankle fractures, patellar dislocations, rotator cuff disorders, and post-surgical recovery. His publication record demonstrates expertise across multiple domains including geriatric orthopaedics, pediatric rehabilitation, sports medicine, and digital health interventions. Recent work focuses on developing targeted rehabilitation protocols for specific populations and conditions, with increasing emphasis on digital health applications and personalized rehabilitation approaches. National Institute for Health and Care Research (NIHR) Postdoctoral Fellowship recipient NIHR Developing Skills Enhancement Award holder Current Chief or co-Investigator on multiple NIHR-funded multicentre clinical trials Professor Keene leads or contributes to numerous research groups including AFTER Feasibility Study, AIM Centre for Rehabilitation Research, GRASP, HIPCARE, PATH-2, PRePPeD, and SPRAINED. His work has been published in high-impact journals including Lancet, JAMA, and BMJ, with recent publications focusing on digital health applications, geriatric fracture care, and pediatric rehabilitation protocols.

Hilary M. DuBrockمشاهده پروفایل

پزشک-پژوهشگر

• Pulmonary Hypertension
• Pulmonary Vascular Complications of Liver Disease
• Hereditary Hemorrhagic Telangiectasia
• +۳ مورد دیگر

Hilary M. DuBrock, MD , is a dual-certified physician scientist in Pulmonary and Critical Care Medicine at the Mayo Clinic in Rochester, Minnesota. With a Master of Medical Sciences (MMSc) in Clinical and Translational Investigation from Harvard Catalyst and fellowship training at Harvard Combined Fellowship Program, her career integrates clinical practice and translational research. Education: MD (University of Massachusetts Medical School, 2008), BS in Physiology and Neurobiology (University of Connecticut, 2003) Her research focuses on pulmonary vascular complications of liver disease , particularly hepatopulmonary syndrome and portopulmonary hypertension , alongside hereditary hemorrhagic telangiectasia (HHT) management. Current work leverages artificial intelligence for early pulmonary hypertension detection and optimizes transplant eligibility criteria through registries. Key publications highlight advancements in treprostinil dosing for interstitial lung disease-associated PH, sleep disturbances in chronic liver patients, and sex differences in portopulmonary hypertension. Awards span transplant research (Dickson Scholar, Mayo Clinic) to early career honors (Alpha Omega Alpha, Phi Beta Kappa). Leadership: Chair of Pulmonary Hypertension Association Registry (2024-present), Core Faculty Member in Mayo's Pulmonary Fellowship Program Professional Affiliations: European Association for the Study of the Liver (2025-present), Pulmonary Hypertension Association (2015-present)

John G. Parkمشاهده پروفایل

پژوهشگر ارشد

• Critical Care Medicine
• Sleep Medicine
• Pulmonary Disease
• +۳ مورد دیگر

Dr. John G. Park is a Research Fellow at the Mayo Clinic College of Medicine and Science, specializing in Pulmonary Medicine , Sleep Medicine , and Critical Care . His work bridges clinical practice and research at Mayo Clinic's Rochester, Minnesota campus. Education : MD from Loyola University (1994), Residency at Cedars-Sinai (1997), Fellowship in Pulmonary/Critical Care (2002) and Sleep Medicine (2003) Board Certifications : Pulmonary Disease, Critical Care Medicine, Sleep Medicine (2009) Research spans critical care outcomes , ventilator-induced lung injury , and Pneumocystis carinii lifecycle . Publications focus on cardiogenic shock epidemiology , PAC utility , and congenital heart disease in ICU . Awards include DOM Humanitarian Award (2024), Internal Medicine Teaching Recognition (2023), and multiple Mayo Clinic Education Honors (2010-2023). Professional leadership roles: Chair of Safety IPE Workgroup , Executive Member of Global Critical Care Collaboration , and Education Committee member at American Academy of Sleep Medicine .

Florent Ginhouxمشاهده پروفایل

پژوهشگر

• Myeloid Cell Biology
• Cancer Immunology
• Tumor Microenvironment
• +۴ مورد دیگر

Florent Ginhoux is a Researcher at Gustave Roussy 's Tumor Immunology and Cancer Immunotherapy Program (U1015). He leads the Florent Ginhoux Laboratory (ginhouxlab.com), focusing on myeloid cell biology in cancer progression and immunotherapy development. His team integrates spatial transcriptomics (Visium HD, Xenium), single-cell RNA sequencing , and MACSIMA spatial proteomics to dissect tumor-immune interactions. His research spans pediatric oncology (brain tumors, neuroblastomas, sarcomas) and adult cancers (pancreatic, head/neck carcinomas). Key projects include Developing iPSC-derived macrophages for patient-specific tumor modeling Characterizing TREM2+ multinucleated macrophages as prognostic indicators Creating MoMac-VERSE and DC-VERSE compendiums for cross-tissue myeloid cell analysis His lab collaborates with pediatric oncologists and bioinformaticians on projects funded by 2024 Fight-Kid Cancer grant ( MiMiC-Kids ) 2024 ANR Excellence Chair ( MATCH ) 2024 Horizon HIT-GLIO grant 2021 INCa PEDIAHRG High-Risk/High-Gain program

• Cardiology
• Cardiovascular Diseases
• Left Ventricular Remodeling
• +۵ مورد دیگر

Professor Andrew Boyle is a distinguished cardiologist and researcher at the University of Newcastle's School of Medicine and Public Health, where he serves as Professor of Cardiovascular Medicine and Head of Discipline. His career spans prestigious institutions including Monash University, St Vincent's Hospital Melbourne, Johns Hopkins University, and the University of California San Francisco, where he was Associate Professor of Medicine. Currently based at the Hunter Medical Research Institute (HMRI) and John Hunter Hospital, he leads significant cardiovascular research initiatives while providing clinical care. Boyle obtained his medical degree from Monash University, completed cardiology advanced training at St Vincent's Hospital Melbourne, earned a PhD in Medicine from the University of Melbourne, and completed fellowship training at Johns Hopkins University. His academic journey includes seven years as faculty at the University of California San Francisco, where his NIH-funded laboratory focused on aging and left ventricular remodeling. Professor Boyle's research focuses on left ventricular remodeling following heart attacks and with aging, with particular emphasis on molecular and cellular mechanisms of fibrosis, cardiac stem cell function, and cardiac regeneration. His laboratory at HMRI employs multiple preclinical models to investigate apoptosis, stem cell behavior, and fibrosis pathways. His translational research bridges laboratory findings with clinical applications, while his clinical research examines systems of care and novel therapies for optimizing cardiovascular outcomes after heart attacks and transcatheter aortic valve implantation. An analysis of his recent publications reveals a strong focus on clinical cardiology research, particularly examining STEMI care disparities between rural and metropolitan regions, innovative interventional techniques, biomarkers for cardiovascular risk prediction, and sex-based differences in heart disease. His work increasingly addresses healthcare system challenges, including rural access to cardiac care and patient-centered approaches to cardiac procedures. Fellow - Society for Cardiac Angiography and Intervention Fellow - American Heart Association Fellow - American College of Cardiology Professor Boyle actively supervises research higher degree students in his laboratory and teaches medical and biomedical science students at all levels. He serves as Clinical Dean of the Hunter Clinical School for the Joint Medical Program of the Universities of Newcastle and New England. His administrative leadership includes roles as Co-Director of the Heart and Stroke Research Program at HMRI, Chair of the Clinical Trials Subcommittee of the Hunter New England HREC, and Chair of the Executive Committee of the NSW Cardiovascular Research Network. His extensive collaborations span Oxford University, multiple Australian universities, the Medical University of Graz, and institutions in China. His research laboratory at HMRI brings together basic scientists, translational researchers, and clinicians to investigate cardiac remodeling mechanisms. The team maintains ongoing collaborations with international institutions and participates in the Regional Rural and Remote Clinical Trial Enabling Program, focusing on improving cardiovascular care delivery in underserved regions.

• Palliative Care
• End-of-Life Care
• Multimorbidity
• +۳ مورد دیگر

Dr. Simon Etkind serves as an Assistant Professor in Palliative Care at the University of Cambridge's School of Clinical Medicine and holds a clinical position as Consultant in Palliative Medicine at Cambridge University Hospitals NHS Foundation Trust. He co-leads the PELiCam Palliative and End of Life Care Research Group within the Department of Public Health and Primary Care, focusing on improving care for individuals with complex multimorbidities and frailty through integrated clinical-academic practice. His educational foundation includes an MB BChir and PhD from King's College London (KCL), establishing dual expertise in clinical medicine and research methodology. This training underpins his current work bridging patient care, medical education, and population health research. Etkind's research program centers on navigating uncertainty in advanced illness trajectories, particularly among older adults with frailty and multimorbidity. He investigates how prognostic uncertainties impact patient care experiences and outcomes, developing strategies to enhance communication and decision-making in ambiguous clinical scenarios. His work spans palliative care integration, symptom management, and ethical considerations in end-of-life care, with emphasis on vulnerable populations often excluded from traditional service models. Analysis of his recent publications reveals consistent focus on uncertainty management across diverse contexts—from community nursing roles to assisted dying debates—with methodological rigor combining qualitative, quantitative, and mixed-methods approaches. Key trends include reframing palliative care needs assessment beyond prognosis, addressing specialty-specific research barriers, and developing practical tools for uncertainty navigation in clinical practice. Scientific recognition includes: Marlow Prize (2023) for pioneering research on virtual reality applications reducing pain and anxiety in acute hospital palliative care settings As an educator, Etkind contributes to medical student teaching at Cambridge and mentors through the UK Palliative Trainees Research Collaborative (UK-PRC), which he co-founded to build national research capacity. His leadership has facilitated over 100 study sites across the UK, fostering a sustainable infrastructure for palliative care innovation. Current projects address prognostic communication, global palliative care needs, and equitable service access. The PELiCam research group functions as an interdisciplinary hub driving evidence-based improvements in palliative care delivery, with active projects spanning community care models, symptom management protocols, and policy-relevant analyses of population needs.

Jason K. Molitorisمشاهده پروفایل

دانشیار

• Radiation Oncology
• Genitourinary Cancers
• Gastrointestinal Cancers
• +۵ مورد دیگر

Dr. Jason K. Molitoris serves as Associate Professor and UMMC Medical Director in the Department of Radiation Oncology at the University of Maryland, based at the Marlene and Stewart Greenebaum Comprehensive Cancer Center. His clinical expertise spans genitourinary, gastrointestinal, central nervous system, and hematologic malignancies, with a focus on implementing advanced radiation technologies to optimize treatment efficacy and minimize side effects. His educational background includes: Bachelor of Science in Biology, Summa cum laude, Phi Beta Kappa, The College of William and Mary MD/PhD through Medical Scientist Training Program, Case Western Reserve University School of Medicine (Alpha Omega Alpha) Internal Medicine Internship, Greater Baltimore Medical Center Radiation Oncology Residency and Chief Residency, University of Maryland Medical Center Dr. Molitoris' research integrates basic science (cell death mechanisms in leukemia/lymphoma) with clinical applications of proton therapy, brachytherapy, and hyperthermia. His work emphasizes novel radiosensitization approaches, clinical trial development, and translational studies to improve outcomes in prostate, gastrointestinal, and CNS cancers while reducing treatment toxicity. Analysis of his 15 most recent publications reveals a strong clinical outcomes focus across brain metastases, lung, breast, and prostate cancers. His work frequently utilizes multi-institutional collaborations and national databases to evaluate prognostic factors, treatment patterns, and advanced technologies like proton therapy, with consistent emphasis on balancing efficacy with quality-of-life preservation. His awards include: Lynn Sage Breast Cancer Symposium Scholar Award RSNA Roentgen Resident/Fellow Research Award International Congress for Hyperthermic Oncology New Investigator Travel Award ASCO/AACR Research Fellow designation American Radium Society Travel Grant Award ASTRO Advocacy Day Travel Grant H.E.R.O. Award nomination University of Maryland Chief Resident distinction Dr. Molitoris actively develops clinical trials through AACR/ASCO workshops and mentors residents, though specific grant details and student advisees aren't documented. His national presentations reflect leadership in radiation oncology innovation, particularly in thermal therapy and proton applications. He operates within the Marlene and Stewart Greenebaum Comprehensive Cancer Center ecosystem, collaborating with multidisciplinary teams across the Maryland Proton Treatment Center and leveraging institutional resources for translational research in advanced radiation modalities.

Katherine Janewayمشاهده پروفایل

دانشیار

• Pediatric Oncology
• Cancer Genomics
• Ewing Sarcoma
• +۴ مورد دیگر

Katherine Janeway, MD, MMSc is an Associate Professor of Pediatrics at Harvard Medical School and serves as Senior Physician at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. She also directs Clinical Genomics at Dana-Farber Cancer Institute. With extensive training including medical school at Harvard, residency in Pediatrics at Boston Combined Residency Program, and fellowship in Pediatric Hematology-Oncology at Boston Children's Hospital and Dana-Farber Cancer Institute, Dr. Janeway has established herself as a leading expert in pediatric bone tumors and cancer genomics. Senior Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center Director of Clinical Genomics, Dana-Farber Cancer Institute Associate Professor of Pediatrics, Harvard Medical School Dr. Janeway's research focuses on pediatric sarcomas, particularly Ewing sarcoma and osteosarcoma. Her work spans the spectrum from basic molecular characterization to clinical trial design and implementation. She has made significant contributions to understanding the genomic landscape of pediatric solid tumors, developing precision medicine approaches, and addressing health disparities in pediatric cancer outcomes. Her research integrates genomics, clinical data, and patient-reported outcomes to improve treatment strategies and survival for children with cancer. Analysis of Dr. Janeway's recent publications reveals a strong emphasis on precision oncology in pediatric cancers, with particular focus on Ewing sarcoma and osteosarcoma. Her work spans molecular characterization, clinical trial design, and implementation of genomic-guided therapies. The publications demonstrate growing integration of patient-reported outcomes, health equity considerations, and data-sharing initiatives in pediatric cancer research. Her leadership in Children's Oncology Group studies highlights her role in shaping the future of pediatric cancer treatment through collaborative, evidence-based approaches. Dr. Janeway has served as principal or co-investigator on numerous clinical trials through the Children's Oncology Group, particularly in the Bone Tumor Committee. Her research has been supported by grants from the National Cancer Institute and other major funding organizations focused on advancing pediatric cancer care through genomic medicine and innovative clinical trial designs. As Director of Clinical Genomics at Dana-Farber Cancer Institute, Dr. Janeway leads initiatives to integrate genomic medicine into clinical care for pediatric cancer patients. She is actively involved in the Pediatric MATCH trial and other precision medicine initiatives that match molecular alterations with targeted therapies for children with cancer.

• Pediatric Oncology
• Palliative Care
• Medical Communication
• +۳ مورد دیگر

Jennifer Mack is a Professor of Pediatrics at Harvard Medical School and Associate Chief of Population Sciences in Pediatric Hematology/Oncology. She practices at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center, focusing on medical communication, palliative care, and pediatric oncology. Education: Harvard Medical School (MD), 1998; Internship/Residency in Pediatrics (1999-2001); Fellowship in Pediatric Hematology-Oncology & Palliative Care (2004) Board Certification: American Board of Pediatrics (Hematology-Oncology) Research Interests: Her work centers on prognostic communication in pediatric oncology, end-of-life care quality , global health disparities , and patient-reported outcome measures . She investigates cultural differences in communication practices, ethical tensions in palliative interventions, and strategies to improve therapeutic alliance. Publication Trends: Recent articles analyze surgeon perspectives on palliative surgery , spiritual communication in brain tumor cases, late effects counseling , and cross-cultural communication in Guatemala, Pakistan, and Japan. Her research spans patient-provider dynamics , decision-making models , and systemic barriers in patient-partnered research.